BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 3:23:00 PM | Browse: 1685 | Download: 1648
 |
Received |
|
2013-01-24 08:38 |
 |
Peer-Review Started |
|
2013-01-24 14:38 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-01-30 15:33 |
 |
Revised |
|
2013-02-23 03:49 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2013-03-08 09:39 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2013-03-08 10:28 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-03-23 21:07 |
 |
Publish the Manuscript Online |
|
2013-03-30 11:26 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Frontier |
| Article Title |
Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
John L Wallace |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Canadian Institutes of Health Research |
|
|
| Corresponding Author |
John L Wallace, PhD, MBA, FRSC, Farncombe Family Digestive Health Research Institute, McMaster University, 1280 Main Street West, HSC-3N4, Hamilton, ON L8S 4K1, Canada. altapharm@hotmail.com
|
| Key Words |
Anti-inflammatory; Ulcer; Prostaglandin; Non-steroidal; Bleeding; Intestinal; Bile; Enterohepatic; Bacteria; Hydrogen sulfide; Aspirin; Hemorrhage |
| Core Tip |
|
| Publish Date |
2013-03-30 11:26 |
| Citation |
Wallace JL. Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy. World J Gastroenterol 2013; 19(12): 1861-1876 |
| URL |
http://www.wjgnet.com/1007-9327/full/v19/i12/1861.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v19.i12.1861 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.